We're redefining what's possible for people with depression—building on decades of work in neuroscience to pioneer the next era of precise, differentiated and impactful treatments. See how: https://lnkd.in/eN-6ha8k
Used to be “Family of Companies”. One of our contractors inadvertently printed “Company of Families”. Also nice! Cheers!
Understanding depression as a circuit-based condition opens the path for more personalized therapies. JNJ is leveraging decades of neuroscience to move beyond general treatments and into targeted approaches. Progress in this area reflects both patient needs and advances in neurobiology.
What usually happens here?
This is exactly what the field needs — precision and differentiation in mental health treatments. Excited to see how neuroscience continues to unlock new pathways for healing and resilience
Amazing!
Pharmaceutical Research & Development Scientist | Formulation Scientist | Scientist, Analytical Development and Quality Control | Analytical Chemistry Techniques | Formulation Development | Regulatory and GMP Knowledge
1wTruly inspiring. Redefining care for depression isn’t just about innovation—it’s about restoring dignity, identity, and hope. Leveraging decades of neuroscience to create precise, differentiated treatments means moving beyond ‘one-size-fits-all’ approaches and finally addressing the unique needs of every patient. Helping people feel like themselves again is more than medicine—it’s transformation.